Current Environment: Production

Recall Alert

There is an antibacterial antibiotic recall. Read more →

Education

Undergraduate School

Radcliffe College

1962, Cambridge, MA

Medical School

Tufts University School of Medicine

1996, Boston, MA

Internship

Grady Memorial Hospital

1967, New Haven, CT

Residency

Yale University School of Medicine

1976, New Haven, CT

Publications

  1. Timing of Retinopathy of Prematurity Diagnosis and Treatment in Micro-Premature and Nano-Premature Infants During Inpatient Screening. Ophthalmol Retina. 2025 May 23. View Abstract

  2. Quantifying the Progression of Stargardt Disease in Double-Null ABCA4 Carriers Using Fundus Autofluorescence Imaging. Transl Vis Sci Technol. 2025 Mar 03; 14(3):16. View Abstract

  3. Characterising the refractive error in paediatric patients with congenital stationary night blindness: a multicentre study. Br J Ophthalmol. 2025 Jan 28; 109(2):286-292. View Abstract

  4. Advancing Insights into Pediatric Macular Diseases: A Comprehensive Review. J Clin Med. 2025 Jan 18; 14(2). View Abstract

  5. Evaluating the Utility of Initial Examinations in Retinopathy of Prematurity: Proposal of FIRST-ROP Algorithm for a Medium-Risk Cohort. Ophthalmology. 2025 Jun; 132(6):713-717. View Abstract

  6. HBS1L deficiency causes retinal dystrophy in a child and in a mouse model associated with defective development of photoreceptor cells. Dis Model Mech. 2024 Aug 01; 17(8). View Abstract

  7. Validation of the "TWO-ROP" Algorithm at a Multi-Neonatal Intensive Care Unit Tertiary Referral Center. Ophthalmol Retina. 2025 Jan; 9(1):63-68. View Abstract

  8. The Surviving, Not Thriving, Photoreceptors in Patients with ABCA4 Stargardt Disease. Diagnostics (Basel). 2024 Jul 17; 14(14). View Abstract

  9. Refractive errors in patients with Bardet Biedl syndrome. Ophthalmic Genet. 2024 Oct; 45(5):435-440. View Abstract

  10. Vision Loss and Difficulty Walking in a Pediatric Sexual Assault Victim. J Neuroophthalmol. 2024 Sep 01; 44(3):e498-e499. View Abstract

  11. KEARNS-SAYRE SYNDROME MASQUERADING AS MYASTHENIA GRAVIS. Retin Cases Brief Rep. 2024 May 01; 18(3):396-399. View Abstract

  12. Ciliopathy patient variants reveal organelle-specific functions for TUBB4B in axonemal microtubules. Science. 2024 04 26; 384(6694):eadf5489. View Abstract

  13. Characteristics of Eyes With CRB1-Associated EOSRD/LCA: Age-Related Changes. Am J Ophthalmol. 2024 07; 263:168-178. View Abstract

  14. Genetic deficiency of ribosomal rescue factor HBS1L causes retinal dystrophy associated with Pelota and EDF1 depletion. bioRxiv. 2023 Oct 20. View Abstract

  15. A Simplified Model of Activation and Deactivation of Human Rod Phototransduction-An Electroretinographic Study. Invest Ophthalmol Vis Sci. 2023 09 01; 64(12):36. View Abstract

  16. The Development of Retinal Function and Refractive Error in Children With Retinopathy of Prematurity. Invest Ophthalmol Vis Sci. 2023 08 01; 64(11):35. View Abstract

  17. Do the retinal abnormalities in X-linked juvenile retinoschisis include impaired phototransduction? Exp Eye Res. 2023 09; 234:109591. View Abstract

  18. Non-Rigid Registration for High-Resolution Retinal Imaging. Diagnostics (Basel). 2023 Jul 06; 13(13). View Abstract

  19. Electroretinographic Responses in Retinopathy of Prematurity Treated Using Intravitreal Bevacizumab or Laser. Am J Ophthalmol. 2023 08; 252:275-285. View Abstract

  20. Microcephaly and chorioretinopathy associated with TUBGCP4: a case report and a review of the literature. Ophthalmic Genet. 2023 Dec; 44(6):585-590. View Abstract

  21. Modelling eye lengths and refractions in the periphery. Ophthalmic Physiol Opt. 2023 07; 43(4):815-826. View Abstract

  22. Insights into the genotype-phenotype relationship of ocular manifestations in Kabuki syndrome. Am J Med Genet A. 2023 05; 191(5):1325-1338. View Abstract

  23. Can Nerve Growth Factor (NGF) Be a Treatment Option for Pediatric Eye Diseases? Semin Ophthalmol. 2023 Jul; 38(5):427-432. View Abstract

  24. Membrane Frizzled-Related Protein-Related Disease Mimicking Idiopathic Intracranial Hypertension. J Neuroophthalmol. 2024 Mar 01; 44(1):e26-e28. View Abstract

  25. The relation of the multifocal electroretinographic response to macular layer volume. Doc Ophthalmol. 2022 08; 145(1):1-10. View Abstract

  26. Longitudinal Change of Refractive Error in Retinopathy of Prematurity Treated With Intravitreal Bevacizumab or Laser Photocoagulation. Am J Ophthalmol. 2022 08; 240:252-259. View Abstract

  27. The Phenotypic and Mutational Spectrum of the FHONDA Syndrome and Oculocutaneous Albinism: Similarities and Differences. Invest Ophthalmol Vis Sci. 2022 01 03; 63(1):19. View Abstract

  28. Evaluation of the Relationship Between Preferential Looking Testing and Visual Evoked Potentials as a Biomarker of Cerebral Visual Impairment. Front Hum Neurosci. 2021; 15:769259. View Abstract

  29. Broadening INPP5E phenotypic spectrum: detection of rare variants in syndromic and non-syndromic IRD. NPJ Genom Med. 2021 Jun 29; 6(1):53. View Abstract

  30. Fundus Pigmentary Whorls in a Patient With Mosaicism for Tetrasomy 3q. JAMA Ophthalmol. 2021 Jun 17. View Abstract

  31. Cerebral visual impairment in CDKL5 deficiency disorder: vision as an outcome measure. Dev Med Child Neurol. 2021 11; 63(11):1308-1315. View Abstract

  32. Artificial Intelligence (AI) Applications for Age-Related Macular Degeneration (AMD) and Other Retinal Dystrophies. Semin Ophthalmol. 2021 May 19; 36(4):304-309. View Abstract

  33. Optical Coherence Tomography Angiography in Prematurity. Semin Ophthalmol. 2021 May 19; 36(4):264-269. View Abstract

  34. Genetic causes of nystagmus, foveal hypoplasia and subnormal visual acuity- other than albinism. Ophthalmic Genet. 2021 06; 42(3):243-251. View Abstract

  35. Dark-adapted threshold and electroretinogram for diagnosis of Usher syndrome. Doc Ophthalmol. 2021 08; 143(1):39-51. View Abstract

  36. Homozygous deletion of 21q22.2 in a patient with hypotonia, developmental delay, cortical visual impairment, and retinopathy. Am J Med Genet A. 2021 02; 185(2):555-560. View Abstract

  37. Carbonic anhydrase inhibition in X-linked retinoschisis: An eye on the photoreceptors. Exp Eye Res. 2021 01; 202:108344. View Abstract

  38. The Fovea in Retinopathy of Prematurity. Invest Ophthalmol Vis Sci. 2020 09 01; 61(11):28. View Abstract

  39. Retinal Function in X-Linked Juvenile Retinoschisis. Invest Ophthalmol Vis Sci. 2019 11 01; 60(14):4872-4881. View Abstract

  40. Extracting the ON and OFF contributions to the full-field photopic flash electroretinogram using summed growth curves. Exp Eye Res. 2019 12; 189:107827. View Abstract

  41. Impact of Obstructive Sleep Apnea on Optic Nerve Function in Patients With Craniosynostosis and Recurrent Intracranial Hypertension. Am J Ophthalmol. 2019 11; 207:356-362. View Abstract

  42. Microperimetry in Three Inherited Retinal Disorders. Semin Ophthalmol. 2019; 34(4):334-339. View Abstract

  43. The migraine eye: distinct rod-driven retinal pathways' response to dim light challenges the visual cortex hyperexcitability theory. Pain. 2019 Mar; 160(3):569-578. View Abstract

  44. Neurobiology of Photophobia. J Neuroophthalmol. 2019 03; 39(1):94-102. View Abstract

  45. High prevalence of strabismic visual field expansion in pediatric homonymous hemianopia. PLoS One. 2018; 13(12):e0209213. View Abstract

  46. Color-selective photophobia in ictal vs interictal migraineurs and in healthy controls. Pain. 2018 Oct; 159(10):2030-2034. View Abstract

  47. ISCEV guide to visual electrodiagnostic procedures. Doc Ophthalmol. 2018 02; 136(1):1-26. View Abstract

  48. The importance of genetic testing as demonstrated by two cases of CACNA1F-associated retinal generation misdiagnosed as LCA. Mol Vis. 2017; 23:695-706. View Abstract

  49. Increased Survival and Partly Preserved Cognition in a Patient With ACO2-Related Disease Secondary to a Novel Variant. J Child Neurol. 2017 08; 32(9):840-845. View Abstract

  50. Juvenile Macular Degenerations. Semin Pediatr Neurol. 2017 05; 24(2):104-109. View Abstract

  51. Multifocal ERG Responses in Subjects With a History of Preterm Birth. Invest Ophthalmol Vis Sci. 2017 05 01; 58(5):2603-2608. View Abstract

  52. Progressive retinal degeneration in a girl with Knobloch syndrome who presented with signs of ocular albinism. Doc Ophthalmol. 2017 04; 134(2):135-140. View Abstract

  53. Available Evidence on Leber Congenital Amaurosis and Gene Therapy. Semin Ophthalmol. 2017; 32(1):14-21. View Abstract

  54. The neural retina in retinopathy of prematurity. Prog Retin Eye Res. 2017 01; 56:32-57. View Abstract

  55. Reduced Left Lateralization of Language in Congenitally Blind Individuals. J Cogn Neurosci. 2017 Jan; 29(1):65-78. View Abstract

  56. Retinal, visual, and refractive development in retinopathy of prematurity. Eye Brain. 2016; 8:103-111. View Abstract

  57. Migraine photophobia originating in cone-driven retinal pathways. Brain. 2016 07; 139(Pt 7):1971-86. View Abstract

  58. Increment Threshold Functions in Retinopathy of Prematurity. Invest Ophthalmol Vis Sci. 2016 05 01; 57(6):2421-7. View Abstract

  59. Expansion of phenotype and genotypic data in CRB2-related syndrome. Eur J Hum Genet. 2016 10; 24(10):1436-44. View Abstract

  60. Differentiation of murine models of "negative ERG" by single and repetitive light stimuli. Doc Ophthalmol. 2016 Apr; 132(2):101-9. View Abstract

  61. Extrafoveal Cone Packing in Eyes With a History of Retinopathy of Prematurity. Invest Ophthalmol Vis Sci. 2016 Feb; 57(2):467-75. View Abstract

  62. Eye growth in term- and preterm-born eyes modeled from magnetic resonance images. Invest Ophthalmol Vis Sci. 2015 May; 56(5):3121-31. View Abstract

  63. Vigabatrin can enhance electroretinographic responses in pigmented and albino rats. Doc Ophthalmol. 2015 Aug; 131(1):1-11. View Abstract

  64. Temporal summation in children with a history of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2015 Jan 20; 56(2):914-7. View Abstract

  65. Panel-based genetic diagnostic testing for inherited eye diseases is highly accurate and reproducible, and more sensitive for variant detection, than exome sequencing. Genet Med. 2015 Apr; 17(4):253-261. View Abstract

  66. Effect of retinopathy of prematurity on scotopic spatial summation. Invest Ophthalmol Vis Sci. 2014 Apr 29; 55(5):3311-3. View Abstract

  67. The rat with oxygen-induced retinopathy is myopic with low retinal dopamine. Invest Ophthalmol Vis Sci. 2013 Dec 19; 54(13):8275-84. View Abstract

  68. The hermansky-pudlak syndrome: clinical features and imperatives from an ophthalmic perspective. Semin Ophthalmol. 2013 Sep-Nov; 28(5-6):387-91. View Abstract

  69. CRB1: one gene, many phenotypes. Semin Ophthalmol. 2013 Sep-Nov; 28(5-6):397-405. View Abstract

  70. Introduction to the special issue: vision after premature birth. Doc Ophthalmol. 2013 Aug; 127(1):1-2. View Abstract

  71. Photoreceptor and postreceptor responses in congenital stationary night blindness. Invest Ophthalmol Vis Sci. 2013 Jul 10; 54(7):4648-58. View Abstract

  72. Next-generation sequencing analysis of gene regulation in the rat model of retinopathy of prematurity. Doc Ophthalmol. 2013 Aug; 127(1):13-31. View Abstract

  73. Alterations of the tunica vasculosa lentis in the rat model of retinopathy of prematurity. Doc Ophthalmol. 2013 Aug; 127(1):3-11. View Abstract

  74. Multimodal adaptive optics retinal imager: design and performance. J Opt Soc Am A Opt Image Sci Vis. 2012 Dec 01; 29(12):2598-607. View Abstract

  75. Electroretinographic (ERG) responses in pediatric patients using vigabatrin. Doc Ophthalmol. 2012 Jun; 124(3):197-209. View Abstract

  76. Effect of carotenoid supplementation on plasma carotenoids, inflammation and visual development in preterm infants. J Perinatol. 2012 Jun; 32(6):418-24. View Abstract

  77. Variations in NPHP5 in patients with nonsyndromic leber congenital amaurosis and Senior-Loken syndrome. Arch Ophthalmol. 2011 Jan; 129(1):81-7. View Abstract

  78. Long-term effects of retinopathy of prematurity (ROP) on rod and rod-driven function. Doc Ophthalmol. 2011 Feb; 122(1):19-27. View Abstract

  79. Cone ERG responses in patients with Smith-Lemli-Opitz Syndrome (SLOS). Doc Ophthalmol. 2010 Oct; 121(2):85-91. View Abstract

  80. Visual cycle modulation in neurovascular retinopathy. Exp Eye Res. 2010 Aug; 91(2):153-61. View Abstract

  81. Deactivation of the rod response in retinopathy of prematurity. Doc Ophthalmol. 2010 Aug; 121(1):29-35. View Abstract

  82. Editorial for special issue: rat models of ROP. Doc Ophthalmol. 2010 Feb; 120(1):1-2. View Abstract

  83. Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial. Lancet. 2009 Nov 07; 374(9701):1597-605. View Abstract

  84. The anatomy of the rat eye with oxygen-induced retinopathy. Doc Ophthalmol. 2010 Feb; 120(1):41-50. View Abstract

  85. The neurovascular retina in retinopathy of prematurity. Prog Retin Eye Res. 2009 Nov; 28(6):452-82. View Abstract

  86. Visual fields in young children treated with vigabatrin. Optom Vis Sci. 2009 Jun; 86(6):767-73. View Abstract

  87. Development of rod function in term born and former preterm subjects. Optom Vis Sci. 2009 Jun; 86(6):E653-8. View Abstract

  88. The neurovascular relation in oxygen-induced retinopathy. Mol Vis. 2008; 14:2499-508. View Abstract

  89. ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol. 2009 Feb; 118(1):69-77. View Abstract

  90. Rod and rod-driven function in achromatopsia and blue cone monochromatism. Invest Ophthalmol Vis Sci. 2009 Feb; 50(2):950-8. View Abstract

  91. Synergistic interaction of the OCA2 and OCA3 genes in a family. Am J Med Genet A. 2008 Sep 15; 146A(18):2427-30. View Abstract

  92. Multifocal ERG responses in infants. Invest Ophthalmol Vis Sci. 2009 Jan; 50(1):470-5. View Abstract

  93. Retinal degenerative and hypoxic ischemic disease. Doc Ophthalmol. 2009 Feb; 118(1):55-61. View Abstract

  94. The cone electroretinogram in retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2008 Feb; 49(2):814-9. View Abstract

  95. Foveal fine structure in retinopathy of prematurity: an adaptive optics Fourier domain optical coherence tomography study. Invest Ophthalmol Vis Sci. 2008 May; 49(5):2061-70. View Abstract

  96. The oscillatory potentials of the dark-adapted electroretinogram in retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2007 Dec; 48(12):5788-97. View Abstract

  97. Effects of desferoxamine on retinal and visual function. Arch Ophthalmol. 2007 Nov; 125(11):1581-2. View Abstract

  98. Development of scotopic visual thresholds in retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2007 Oct; 48(10):4854-60. View Abstract

  99. The genetics and ocular findings of Alagille syndrome. Semin Ophthalmol. 2007 Oct-Dec; 22(4):205-10. View Abstract

  100. Rod photoreceptor function predicts blood vessel abnormality in retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2007 Sep; 48(9):4351-9. View Abstract

  101. Retinal degeneration in children: dark adapted visual threshold and arteriolar diameter. Vision Res. 2008 Feb; 48(3):325-31. View Abstract

  102. Development of the electroretinographic oscillatory potentials in normal and ROP rats. Invest Ophthalmol Vis Sci. 2006 Dec; 47(12):5447-52. View Abstract

  103. Pediatric clinical visual electrophysiology: a survey of actual practice. Doc Ophthalmol. 2006 Nov; 113(3):193-204. View Abstract

  104. The retinal vasculature and function of the neural retina in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2006 Jun; 47(6):2639-47. View Abstract

  105. Proceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery (November 2003, Anaheim, California). Mol Vis. 2006 May 23; 12:532-80. View Abstract

  106. Multifocal ERG in subjects with a history of retinopathy of prematurity. Doc Ophthalmol. 2005 Jul; 111(1):7-13. View Abstract

  107. X-linked creatine transporter defect: a report on two unrelated boys with a severe clinical phenotype. J Inherit Metab Dis. 2006 Feb; 29(1):214-9. View Abstract

  108. Diagnosis of plus disease in retinopathy of prematurity using Retinal Image multiScale Analysis. Invest Ophthalmol Vis Sci. 2005 Dec; 46(12):4734-8. View Abstract

  109. Development of the cone ERG in infants. Invest Ophthalmol Vis Sci. 2005 Sep; 46(9):3458-62. View Abstract

  110. Development of visual acuity in children with cerebral visual impairment. Arch Ophthalmol. 2005 Sep; 123(9):1215-20. View Abstract

  111. Maculopathy and retinal degeneration in cobalamin C methylmalonic aciduria and homocystinuria. Arch Ophthalmol. 2005 Aug; 123(8):1143-6. View Abstract

  112. Early ametropia and rod photoreceptor function in retinopathy of prematurity. Optom Vis Sci. 2005 Apr; 82(4):307-17. View Abstract

  113. ERG oscillatory potentials in infants. Doc Ophthalmol. 2005 Mar-May; 110(2-3):265-70. View Abstract

  114. Recovery of the rod photoresponse in infants. Invest Ophthalmol Vis Sci. 2005 Feb; 46(2):764-8. View Abstract

  115. Comparison of ERGs recorded with skin and corneal-contact electrodes in normal children and adults. Doc Ophthalmol. 2004 Jul; 109(1):43-55. View Abstract

  116. Recovery of the rod photoresponse in infant rats. Vision Res. 2003 Dec; 43(28):3081-5. View Abstract

  117. Rod photoreceptor responses in children with Smith-Lemli-Opitz syndrome. Arch Ophthalmol. 2003 Dec; 121(12):1738-43. View Abstract

  118. Development of ERG responses: the ISCEV rod, maximal and cone responses in normal subjects. Doc Ophthalmol. 2003 Nov; 107(3):235-41. View Abstract

  119. Effects of telazol and nembutal on retinal responses. Doc Ophthalmol. 2003 Jul; 107(1):45-51. View Abstract

  120. Retinal function in carriers of Bardet-Biedl syndrome. Arch Ophthalmol. 2003 Jun; 121(6):804-10. View Abstract

  121. Evaluation of complex inheritance involving the most common Bardet-Biedl syndrome locus (BBS1). Am J Hum Genet. 2003 Feb; 72(2):429-37. View Abstract

  122. Rod photoreceptor function in children with mitochondrial disorders. Arch Ophthalmol. 2002 Aug; 120(8):1055-62. View Abstract

  123. Identification of the gene (BBS1) most commonly involved in Bardet-Biedl syndrome, a complex human obesity syndrome. Nat Genet. 2002 Aug; 31(4):435-8. View Abstract

  124. Fundus photography for measurement of macular pigment density distribution in children. Invest Ophthalmol Vis Sci. 2002 May; 43(5):1450-5. View Abstract

  125. Background adaptation in a rat model of retinopathy of prematurity. Doc Ophthalmol. 2002 Jan; 104(1):97-105. View Abstract

  126. Novel frameshift mutations in CRX associated with Leber congenital amaurosis. Hum Mutat. 2001 Dec; 18(6):550-1. View Abstract

  127. Cycloplegic refractions in healthy children aged 1 through 48 months. Arch Ophthalmol. 2001 Nov; 119(11):1625-8. View Abstract

  128. Positional cloning of a novel gene on chromosome 16q causing Bardet-Biedl syndrome (BBS2). Hum Mol Genet. 2001 Apr 01; 10(8):865-74. View Abstract

  129. The rod photoreceptors in retinopathy of prematurity: an electroretinographic study. Arch Ophthalmol. 2001 Apr; 119(4):499-505. View Abstract

  130. Mutations in the CRB1 gene cause Leber congenital amaurosis. Arch Ophthalmol. 2001 Mar; 119(3):415-20. View Abstract

  131. Cortical visual impairment in infants and children. Int Ophthalmol Clin. 2001; 41(1):159-69. View Abstract

  132. Rod-mediated increment threshold functions in infants. Invest Ophthalmol Vis Sci. 2000 Dec; 41(13):4347-52. View Abstract

  133. The development of scotopic sensitivity. Invest Ophthalmol Vis Sci. 2000 May; 41(6):1588-96. View Abstract

  134. Background adaptation in children with a history of mild retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2000 Jan; 41(1):320-4. View Abstract

  135. The rhodopsin content of human eyes. Invest Ophthalmol Vis Sci. 1999 Jul; 40(8):1878-83. View Abstract

  136. The course of maturation of rod-mediated visual thresholds in infants. Invest Ophthalmol Vis Sci. 1999 Jul; 40(8):1883-6. View Abstract

  137. Rod photoreceptor maturation does not vary with retinal eccentricity in mammalian retina. Curr Eye Res. 1999 Jun; 18(6):393-402. View Abstract

  138. Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky-Pudlak syndrome) [correction of (Hennansky-Pudlak)]. Arch Ophthalmol. 1999 Feb; 117(2):251-2. View Abstract

  139. Rod photoreceptors in infant rats with a history of oxygen exposure. Invest Ophthalmol Vis Sci. 1999 Jan; 40(1):168-74. View Abstract

  140. Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or leber congenital amaurosis. Proc Natl Acad Sci U S A. 1998 Mar 17; 95(6):3088-93. View Abstract

  141. Rod and rod mediated function in patients with beta-thalassemia major. Doc Ophthalmol. 1998-1999; 96(4):333-45. View Abstract

  142. Central retinal vein occlusion in a young child with cyanotic heart disease. Arch Ophthalmol. 1997 Aug; 115(8):1077. View Abstract

  143. Dark-adapted thresholds in children with histories of mild retinopathy of prematurity. Invest Ophthalmol Vis Sci. 1997 May; 38(6):1175-83. View Abstract

  144. Rhodopsin in immature rod outer segments. Invest Ophthalmol Vis Sci. 1996 Sep; 37(10):1951-6. View Abstract

  145. Vision in Leber congenital amaurosis. Arch Ophthalmol. 1996 Jun; 114(6):698-703. View Abstract

  146. Photoreceptor function in infants and children with a history of mild retinopathy of prematurity. J Opt Soc Am A Opt Image Sci Vis. 1996 Mar; 13(3):566-71. View Abstract

  147. Effect of prior oxygen exposure on the electroretinographic responses of infant rats. Invest Ophthalmol Vis Sci. 1995 Sep; 36(10):2071-9. View Abstract

  148. The effects of acetazolamide on the electroretinographic responses in rats. Invest Ophthalmol Vis Sci. 1995 May; 36(6):1019-26. View Abstract

  149. The development of the rod photoresponse from dark-adapted rats. Invest Ophthalmol Vis Sci. 1995 May; 36(6):1038-45. View Abstract

  150. The course of myopia in children with mild retinopathy of prematurity. Vision Res. 1995 May; 35(9):1329-35. View Abstract

  151. Dark-adapted thresholds at 10- and 30-deg eccentricities in 10-week-old infants. Vis Neurosci. 1995 May-Jun; 12(3):509-12. View Abstract

  152. The VEP thresholds for full-field stimuli in dark-adapted infants. Vis Neurosci. 1995 Mar-Apr; 12(2):223-8. View Abstract

  153. Electroretinogram responses and refractive errors in patients with a history of retinopathy prematurity. Doc Ophthalmol. 1995-1996; 91(2):87-100. View Abstract

  154. Scotopic optokinetic nystagmus thresholds in 10-week-old infants. Invest Ophthalmol Vis Sci. 1994 Mar; 35(3):1246-9. View Abstract

  155. Scotopic center surround organization in 10-week-old infants. Vision Res. 1994 Mar; 34(5):621-4. View Abstract

  156. Clinical physiology of heritable photoreceptor diseases. Arch Ophthalmol. 1993 Nov; 111(11):1479-81. View Abstract

  157. Natural course of visual functions in the Bardet-Biedl syndrome. Arch Ophthalmol. 1993 Nov; 111(11):1500-6. View Abstract

  158. The rod sensitivity of dark adapted human infants. Curr Eye Res. 1992 Dec; 11(12):1193-8. View Abstract

  159. Screening preschool children to detect visual and ocular disorders. Arch Ophthalmol. 1992 Nov; 110(11):1553-4. View Abstract

  160. Effects of halothane on children's electroretinograms. Ophthalmology. 1992 Aug; 99(8):1309-12. View Abstract

  161. The effect of light adaptation on scotopic spatial summation in 10-week-old infants. Vision Res. 1992 Feb; 32(2):387-92. View Abstract

  162. Albinism. Int Ophthalmol Clin. 1992; 32(1):185-200. View Abstract

  163. The quantity of rhodopsin in young human eyes. Curr Eye Res. 1991 Oct; 10(10):977-82. View Abstract

  164. Visual development of infants with severe ocular disorders. Ophthalmology. 1991 Aug; 98(8):1306-9. View Abstract

  165. Delayed visual maturation. Lancet. 1991 Jun 01; 337(8753):1350. View Abstract

  166. Dark adapted thresholds in young RCS rats. Vision Res. 1991; 31(4):637-42. View Abstract

  167. Temporal summation in dark-adapted 10-week old infants. Vision Res. 1991; 31(7-8):1259-69. View Abstract

  168. Electroretinographic assessment of background adaptation in 10-week-old human infants. Vision Res. 1991; 31(9):1501-7. View Abstract

  169. The quantity of rhodopsin in human eyes. Curr Eye Res. 1990 Dec; 9(12):1211-6. View Abstract

  170. Hyperopia in complicated Leber's congenital amaurosis. Arch Ophthalmol. 1990 May; 108(5):709-12. View Abstract

  171. Dark adaptation in hyperprolactinemic women. Invest Ophthalmol Vis Sci. 1989 Jun; 30(6):1177-80. View Abstract

  172. Electrophysiologic testing techniques for children. Doc Ophthalmol. 1989 Apr; 71(4):341-54. View Abstract

  173. Psychophysical estimates of ocular media density of human infants. Vision Res. 1989; 29(6):687-90. View Abstract

  174. Visual acuities and dark-adapted thresholds of children with Bardet-Biedl syndrome. Am J Ophthalmol. 1988 Nov 15; 106(5):561-9. View Abstract

  175. Visual fields of young children. Behav Brain Res. 1988 Jul; 29(1-2):7-16. View Abstract

  176. The development of scotopic retinal function in human infants. Doc Ophthalmol. 1988 Jun; 69(2):101-9. View Abstract

  177. Visual fields of infants assessed with a new perimetric technique. Invest Ophthalmol Vis Sci. 1988 Mar; 29(3):452-9. View Abstract

  178. Scotopic stimulus/response relations of the B-wave of the electroretinogram. Doc Ophthalmol. 1988 Mar-Apr; 68(3-4):293-304. View Abstract

  179. The relation of rhodopsin and scotopic retinal sensitivity in sector retinitis pigmentosa. Am J Ophthalmol. 1988 Feb 15; 105(2):132-40. View Abstract

  180. Optokinetic nystagmus thresholds of dark-adapted RCS rats. Vision Res. 1988; 28(7):761-4. View Abstract

  181. Esotropic children with amblyopia: effects of patching on acuity. Graefes Arch Clin Exp Ophthalmol. 1988; 226(4):309-12. View Abstract

  182. Special diagnostic and therapeutic modalities in pediatric ophthalmology. Pediatr Clin North Am. 1987 Dec; 34(6):1543-53. View Abstract

  183. The relation of rhodopsin and scotopic sensitivity in choroideremia. Am J Ophthalmol. 1987 Nov 15; 104(5):524-32. View Abstract

  184. Oscillatory potentials of visually inattentive children. Doc Ophthalmol. 1987 Mar; 65(3):319-32. View Abstract

  185. Foveal cone pigments and sensitivity in young patients with Usher's syndrome. Am J Ophthalmol. 1987 Feb 15; 103(2):150-60. View Abstract

  186. Intramuscular vitamin E repletion in children with chronic cholestasis. Am J Dis Child. 1987 Feb; 141(2):170-4. View Abstract

  187. Concurrence of congenital ocular motor apraxia and other motor problems: an expanded syndrome. Dev Med Child Neurol. 1987 Feb; 29(1):85-90. View Abstract

  188. The relationship of retinal sensitivity and rhodopsin in human infants. Vision Res. 1987; 27(5):697-704. View Abstract

  189. "Self-screening" of rhodopsin in rod outer segments. Vision Res. 1987; 27(9):1459-70. View Abstract

  190. Pupillary changes during dark adaptation in human infants. Invest Ophthalmol Vis Sci. 1986 Dec; 27(12):1726-9. View Abstract

  191. Assessment of acuity of amblyopic subjects using face, grating, and recognition stimuli. Invest Ophthalmol Vis Sci. 1986 Jul; 27(7):1184-7. View Abstract

  192. Background adaptation in human infants. Vision Res. 1986; 26(5):771-9. View Abstract

  193. Electroretinography: application to clinical studies of infants. J Pediatr Ophthalmol Strabismus. 1985 Nov-Dec; 22(6):251-5. View Abstract

  194. Assessment of young amblyopes. Array vs. single picture acuities. Ophthalmology. 1985 Sep; 92(9):1197-202. View Abstract

  195. Retinal degenerations and brain abnormalities in infants and young children. Doc Ophthalmol. 1985 Aug 30; 60(2):133-40. View Abstract

  196. Visual acuity of infants and children with retinal degenerations. Ophthalmic Paediatr Genet. 1985 Feb; 5(1-2):51-6. View Abstract

  197. Preferential looking grating acuities of infants at risk of amblyopia. Trans Ophthalmol Soc U K (1962). 1985; 104 ( Pt 8):903-11. View Abstract

  198. Grating and recognition acuities of pediatric patients. Ophthalmology. 1984 Aug; 91(8):947-53. View Abstract

  199. Assessment of acuity in human infants using face and grating stimuli. Invest Ophthalmol Vis Sci. 1984 Jul; 25(7):782-6. View Abstract

  200. The relation of retinal sensitivity and rhodopsin in developing rat retina. Invest Ophthalmol Vis Sci. 1984 Jun; 25(6):647-51. View Abstract

  201. Retinal degeneration in vitamin B12 disorder associated with methylmalonic aciduria and sulfur amino acid abnormalities. Am J Ophthalmol. 1984 Jun; 97(6):691-6. View Abstract

  202. Cycloplegic refractions of infants and young children: the axis of astigmatism. Invest Ophthalmol Vis Sci. 1984 Jan; 25(1):83-7. View Abstract

  203. Retinal sensitivity and adaptation in pediatric patients. Behav Brain Res. 1983 Oct; 10(1):59-70. View Abstract

  204. Preferential looking acuity of pediatric patients with developmental disabilities. Behav Brain Res. 1983 Oct; 10(1):189-97. View Abstract

  205. Background adaptation in RCS rats. Invest Ophthalmol Vis Sci. 1983 Jan; 24(1):72-6. View Abstract

  206. Preferential looking vision testing: application to evaluation of high-risk, prematurely born infants and children. J Pediatr Ophthalmol Strabismus. 1982 Nov-Dec; 19(6):286-93. View Abstract

  207. Preferential looking acuity obtained with a staircase procedure in pediatric patients. Invest Ophthalmol Vis Sci. 1982 Oct; 23(4):538-43. View Abstract

  208. Scotopic thresholds and plasma retinol in cystic fibrosis. Invest Ophthalmol Vis Sci. 1982 Sep; 23(3):364-70. View Abstract

  209. The relation of myopia and astigmatism in developing eyes. Ophthalmology. 1982 Apr; 89(4):298-302. View Abstract

  210. Dark-adapted sensitivity, rhodopsin content, and background adaptation in pcd/pcd mice. Invest Ophthalmol Vis Sci. 1982 Mar; 22(3):386-93. View Abstract

  211. Development of the outer plexiform layer in albino rats. Curr Eye Res. 1982-1983; 2(5):295-9. View Abstract

  212. Retinal degeneration in the delayed amelanotic (DAM) chicken: an electroretinographic study. Curr Eye Res. 1982-1983; 2(11):757-63. View Abstract

  213. Behavioral measurement of background adaptation in infants. Invest Ophthalmol Vis Sci. 1981 Oct; 21(4):625-9. View Abstract

  214. Cycloplegic refractions of premature infants. Am J Ophthalmol. 1981 Apr; 91(4):490-5. View Abstract

  215. Cone pigments in acute posterior multifocal placoid pigment epitheliopathy. Am J Ophthalmol. 1981 Apr; 91(4):465-8. View Abstract

  216. Measuring visual acuity in infants. Surv Ophthalmol. 1981 Mar-Apr; 25(5):325-32. View Abstract

  217. Cycloplegic refractions in infants and young children. Am J Ophthalmol. 1980 Aug; 90(2):239-47. View Abstract

  218. Increased incidence of choroidal malignant melanoma occurring in a single population of chemical workers. Am J Ophthalmol. 1980 Mar; 89(3):323-37. View Abstract

  219. Background adaptation in developing rat retina: an electroretinographic study. Vision Res. 1980; 20(10):819-26. View Abstract

  220. Retinal anomalies in trisomy 18. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1980; 213(3):195-205. View Abstract

  221. Epidemikological investigation of increased incidence of choroidal melanoma in a single population of chemical workers. Int Ophthalmol Clin. 1980; 20(2):71-92. View Abstract

  222. Infant vision testing by a behavioral method. Ophthalmology. 1979 Mar; 86(3):431-9. View Abstract

  223. A behavioral method for efficient screening of visual acuity in young infants. II. Clinical application. Invest Ophthalmol Vis Sci. 1978 Dec; 17(12):1151-7. View Abstract

  224. Human retinal dysplasia. Am J Ophthalmol. 1978 May; 85(5 Pt 1):690-8. View Abstract

  225. Human albinism. Light and electron microscopy study. Arch Ophthalmol. 1978 Feb; 96(2):305-10. View Abstract

  226. Rod ERG of the mudpuppy: effect of dim red backgrounds. Vision Res. 1978; 18(7):785-92. View Abstract

  227. The human rod ERG: correlation with psychophysical responses in light and dark adaptation. Vision Res. 1978; 18(7):793-800. View Abstract

  228. Ocular findings in triploidy. Am J Ophthalmol. 1977 Dec; 84(6):859-67. View Abstract

  229. Spontaneous anophthalmia and microphthalmia in white-tailed deer. J Comp Pathol. 1977 Oct; 87(4):557-68. View Abstract

  230. Comparative ophthalmic pathology. Invest Ophthalmol. 1976 Dec; 15(12):975-8. View Abstract

  231. Active giant cell arteritis with cerebral involvement. Findings following four years of corticosteroid therapy. Arch Ophthalmol. 1976 Dec; 94(12):2068-71. View Abstract

  232. Gastrointestinal sarcoidosis diagnosed by conjunctival biopsy. Am J Ophthalmol. 1976 Jul; 82(1):102-4. View Abstract

  233. Dark adaptation and the rate of pigment regeneration. Vision Res. 1969 Dec; 9(12):1473-9. View Abstract

  234. Dark adaptation: free opsin or regeneration rate? J Physiol. 1969 Oct; 204(2):124P+. View Abstract

Education

Undergraduate School

Yale University

1994, New Haven, CT

Graduate School

MMSc

Harvard University / Massachusetts Institute of Technology

Cambridge, MA

Medical School

Johns Hopkins School of Medicine

1998, Baltimore, MD

Internship

Pediatrics

Boston Combined Residency Program (BCRP)

1999, Boston, MA

Residency

Pediatrics

Boston Combined Residency Program (BCRP)

2001, Boston, MA

Fellowship

Pediatric Endocrinology

Boston Children's Hospital

2005, Boston, MA

Publications

Education

Undergraduate School

Yale University

2004, New Haven, CT

Medical School

Stanford University

2010, Palo Alto, CA

Internship

Massachusetts General Hospital

2011, Boston, MA

Residency

Massachusetts General Hospital

2017, Boston, MA

Fellowship

Boston Children's Hospital

2018, Boston, MA

Publications

Education

Undergraduate School

Villanova University

1989, Villanova, PA

Medical School

New York Medical College

1993, Valhalla, NY

Internship

Naval Medical Center

1993, San Diego, CA

Residency

Cincinnati Children's Hospital

2001, Cincinnati, OH

Education

Medical School

Northwestern University Medical School

1986, Chicago, IL

Internship

Hospital of University of Pennsylvania

1987, Philadelphia, PA

Residency

Hospital of University of Pennsylvania

1992, Philadelphia, PA

Fellowship

Surgery

University of Pennsylvania School of Medicine

1990, Philadelphia, PA

Fellowship

Pediatric Surgery

Boston Children's Hospital

1994, Boston, MA

Publications

Education

Undergraduate School

Yale University

1988, New Haven, CT

Medical School

Harvard Medical School

1993, Boston, MA

Internship

Boston Children's Hospital

1997, Boston, MA

Residency

Boston Children's Hospita

1998, Boston, MA

Education

Undergraduate School

St. Lawrence University

1992, Canton, NY

Medical School

University of Vermont College of Medicine

2001, Burlington, VT

Internship

Pediatrics

University of Vermont/Fletcher Allen Health Care

2002, Burlington, VT

Residency

Pediatrics

University of Vermont/Fletcher Allen Health Care

2004, Burlington, VT

Residency

Chief Resident in Pediatrics

University of Vermont/Fletcher Allen Health Care

2005, Burlington, VT

Fellowship

Pediatric Nephrology

Boston Children's Hospital

2008, Boston, MA

Publications

Education

Undergraduate School

Tufts University

Medford, MA

Medical School

Boston University School of Medicine

Boston, MA

Internship

Hasbro Children's Hospital

Providence, RI

Residency

Hasbro Children's Hospital

Providence, RI
Subscribe to English

Talk to Lesley

If this is a medical emergency, please dial 9-1-1. This application should not be used in an emergency. This chat is being transmitted via a secure connection.

Hi! My name is Lesley. I am a virtual agent programmed to help you. If you would like to speak to a live agent, please call 617-355-6000.

I am unable to answer specific questions regarding your child's case, including appointments and conditions/diagnosis. Please contact your physician's office.

Quick links:

- MyChildrens Portal
- Global Services
- Find a Doctor
- Find a Location
- Programs and Services